UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 143 filers reported holding THERAVANCE INC in Q3 2013. The put-call ratio across all filers is 0.30 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$505,000
+13.2%
47,897
-22.9%
0.00%
Q3 2015$446,000
-33.8%
62,149
+66.6%
0.00%
-100.0%
Q2 2015$674,000
+34.5%
37,297
+16.9%
0.00%
Q1 2015$501,000
+17.3%
31,897
+5.6%
0.00%
Q4 2014$427,000
-93.7%
30,197
-92.4%
0.00%
-100.0%
Q3 2014$6,800,000
-70.4%
397,897
-48.4%
0.01%
-69.6%
Q2 2014$22,942,000
-0.9%
770,397
+2.9%
0.02%
-8.0%
Q1 2014$23,159,000
+2.1%
748,497
+17.6%
0.02%
-3.8%
Q4 2013$22,688,000
-13.3%
636,397
-0.5%
0.03%
-18.8%
Q3 2013$26,165,000
+21.4%
639,897
+14.3%
0.03%
+14.3%
Q2 2013$21,561,000559,5970.03%
Other shareholders
THERAVANCE INC shareholders Q3 2013
NameSharesValueWeighting ↓
Baupost Group 19,815,983$280,396,0005.51%
Litespeed Management, L.L.C. 2,670,695$37,790,0003.56%
PERRY CAPITAL 4,026,736$56,978,0002.38%
Krensavage Asset Management, LLC 171,859$2,432,0001.36%
Empyrean Capital Partners, LP 1,679,889$23,770,0001.35%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,506,771$35,471,0001.35%
Roundview Capital LLC 221,507$3,134,0001.29%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,216,222$130,410,0001.21%
Proxima Capital Management, LLC 417,434$5,907,0000.77%
Alden Global Capital Ltd 195,700$2,769,0000.67%
View complete list of THERAVANCE INC shareholders